Home Compare AFX.DE vs SDZ.SW
Stock Comparison · Structural lead, mixed market

Carl Zeiss Meditec vs Sandoz Group: Which Stock Looks Stronger in 2026?

Sandoz holds the cleaner structural position, with the lead spread across growth and valuation. Carl Zeiss Meditec still has the edge on valuation, which keeps the comparison from looking entirely one-sided. On the market side, Sandoz is in better shape — its trend is intact while Carl Zeiss Meditec's trend has broken down. That puts structure and market broadly in agreement — Sandoz's lead looks more confirmed than conflicted.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The clearest separation starts in growth, but stability adds another real layer to the result.

Trajectory Similarity
0.71
Similar
Peer-set rank: #7
within Carl Zeiss Meditec AG's functional peer set

This pair is matched through long-term financial trajectory similarity within the selected peer universe.

The pair sits on a clearly comparable long-term path, though it is not a near-twin match.

The strongest overlap appears in capital structure and revenue stability.

Similarity drivers
capital structurerevenue stability
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
AFX.DE
Carl Zeiss Meditec AG
47
Peer-Score
Signal qualityHigh
vs
SDZ.SW
Sandoz Group AG
53
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: AFX.DE vs SDZ.SW Profitability 35 51 Stability 24 51 Valuation 86 36 Growth 28 84 AFX.DE SDZ.SW
Gap Ranking
#1 Growth +56
#2 Valuation +50
#3 Stability +27
#4 Profitability +16
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for AFX.DE and SDZ.SW Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer AFX.DESDZ.SW Relative valuation Structural strength

Sandoz Group AG is cheaper, but Carl Zeiss Meditec AG is still stronger.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
On growth, Sandoz Group AG ranks near the top of the group; Carl Zeiss Meditec AG sits in the weaker half.
Valuation
The same broad pattern appears on valuation: Carl Zeiss Meditec AG ranks near the top of the group, while Sandoz Group AG stays in the weaker half.
Growth — Dominant Gap
AFX.DE
28
SDZ.SW
84
Gap+56in favour of SDZ.SW

One company is still expanding while the other is contracting, which creates a very wide growth split.

What keeps the gap from being one-sided

Absolute pricing still looks more supportive for Carl Zeiss Meditec, with a forward P/E that is 4.7 turns lower there.

What this means for the comparison

The growth edge is decisive, even though current pricing and valuation still lean somewhat toward Carl Zeiss Meditec AG.

Explore full peer positioning in AssetNext

Break down the AFX.DE vs SDZ.SW comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how AFX.DE and SDZ.SW each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.